Intravenous Bisphosphonate Therapy in the Adult Patient with Osteogenesis Imperfecta: A Literature Review and Case Report
Haydn James Taylor, Stephanie Cox, Jennifer Georgina Martins & Michael O'Halloran · International Journal of Medical and Pharmaceutical Case Reports · 2015
Osteogenesis Imperfecta (OI) defines a group of genetically varied connective tissue disorders where intravenous bisphosphonate (BP) therapy is common to manage the associated bone fragility. Due to this bone fragility, there is potential for these patients to be regarded as a hi...
Open access
Research Article
10.9734/IJMPCR/2015/19425